Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Medication Source Code Verification: Student 2 (UPDATED 08/7/19) #113

Open
2 of 7 tasks
callahantiff opened this issue Aug 7, 2019 · 5 comments
Open
2 of 7 tasks
Assignees
Labels
source code verification verification of source string to source code mappings

Comments

@callahantiff
Copy link
Owner

callahantiff commented Aug 7, 2019

Student (GitHub Username): @WhitleyMcCall
Verification Number: 2

Assigned Domain Expert: @trinklek

Verification Task Description: DropBox Paper Documentation

Phenotype Descriptions: project wiki

Verification Assignments:
UPDATES: this is replacing the original dashboard utilized by AVM (archived here)

Verification Assignments:

@callahantiff
Copy link
Owner Author

UPDATE: @WhitleyMcCall and I decided during our meeting today that she will only re-verify the ADHD phenotype mappings (which @avnmatre mapped) if their is time (and it makes sense) after the rest of the phenotypes have been verified.

@trinklek
Copy link
Collaborator

trinklek commented Aug 8, 2019

UPDATE: @WhitleyMcCall and I decided during our meeting today that she will only re-verify the ADHD phenotype mappings (which @avnmatre mapped) if their is time (and it makes sense) after the rest of the phenotypes have been verified.

Sounds great and efficient!

@WhitleyMcCall
Copy link
Collaborator

@callahantiff @trinklek
For now, I am leaving the "Not Phenotype Relevant" box unchecked for topical betamethasone in order for a discussion on possibly including it. Topical steroids are not part of the phenotype criteria, but as a moderate to very high potency steroid, topical betamethasone use can cause sufficient systemic absorption for HPA axis suppression, and long-term use poses a risk for systemic adverse effects, such as osteonecrosis. However, if including topical betamethasone in the phenotype definition we would likely need to define criteria (e.g. duration same as other routes at 14 days? all potencies/formulations?)

@trinklek
Copy link
Collaborator

@callahantiff @trinklek
For now, I am leaving the "Not Phenotype Relevant" box unchecked for topical betamethasone in order for a discussion on possibly including it. Topical steroids are not part of the phenotype criteria, but as a moderate to very high potency steroid, topical betamethasone use can cause sufficient systemic absorption for HPA axis suppression, and long-term use poses a risk for systemic adverse effects, such as osteonecrosis. However, if including topical betamethasone in the phenotype definition we would likely need to define criteria (e.g. duration same as other routes at 14 days? all potencies/formulations?)

@WhitleyMcCall @callahantiff Great thought Whitley! Should we plan a call to discuss this and any other issues? I am out of the country 8/31-9/18 so perhaps before then? Let me know what works best for you all!

@WhitleyMcCall
Copy link
Collaborator

@callahantiff @trinklek What about a call next week or weekend? I'm free Thursday evening (8/22) and Friday evening (8/23) or any time Sat/Sun (8/24-25)

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
source code verification verification of source string to source code mappings
Projects
None yet
Development

No branches or pull requests

3 participants